#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Jim Thomson Email
SVP Research & Development . Polaris Pharmaceuticals
How to contact Jim Thomson
Join and see Jim's contact info for free!Current Roles
Employees:
28Revenue:
$7.2MAbout
Polaris Group, a privately held multinational biopharmaceutical drug company, specializes in the research and development of protein drugs to treat cancer and other debilitating diseases in humans. Polaris' lead project is ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma. Polaris is collaborating with EnzymeRx in the development of Uricase-PEG 20 for the treatment of gout, tumor lysis syndrome, and other diseases related to hyperuricemia. Polaris is also researching and developing other biotherapeutic agents and has a small molecule drug program. The latter utilizes a rational structure-based approach for the design of novel compounds that inhibit the biological function of cancer-related protein targets.Polaris Pharmaceuticals Address
6370 Nancy Ridge Drive, Suite 106San Diego, CA
United States